Users reported everything from less drive to a libido through the roof. If youre on these, dont panic
Tirzepatide: MEDVi Launches Physician-Led Program to Help Patien MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program designed to help patients navigate the decision between semaglutide and tirzepatide, two GLP-1 medications at the center of the weight loss conversation in 2026 Image: Disclosure: This announcement is for informational purposes only and does not constitute medical advice
43,76 The results of the 52-week MAESTRO-NAFLD-1 trial supported the efficacy and safety of resmetirom at doses of 80 mg and 100 mg qd (NCT04197479), which are being applied in the ongoing phase 3 MASH study, MAESTRO-NASH
"Las nuevas opciones de tratamiento traen esperanza a las muchas personas con obesidad que luchan contra esta enfermedad y buscan mejores opciones para controlar el peso", declar Joe Nadglowski, presidente y director ejecutivo de Obesity Action Coalition
This gut health optimization has far-reaching effects on overall wellness and disease prevention
Summary: There is no established causal link between Mounjaro (tirzepatide) and diverticulitis based on current clinical trial data and post-marketing surveillance
